For the use of healthy horses of all ages as a aid in the prevention of disease (strangles) due to Streptococcus equi infection. Dosage: Using aseptic technique, inject 1 ml intramuscularly, preferably in the hind quarters. For primary vaccination give 3 doses at intervals of 3 weeks. Foals vaccinated when less than 3 months of age should receive an additional dose at 6 months. Revaccinate annually and prior to anticipated exposure, using a single 1 ml dose. Use a separate needle for each injection.
! We recommend ordering vaccines during the first part of the week. To reduce the chance of your vaccine order being exposed to excessive heat or cold, use overnite or priority mail delivery. Vaccines shipped by any other method cannot be returned.
This treatment applies to the following species:
•Horses
Manufacturer: Boehringer Ingelheim
Streptococcus Equi Bacterial Extract
For Veterinary Use Only
Strepvax II Indications
For use in healthy horses of all ages as an aid in the prevention of disease (strangles) due to Streptococcus equi infection.
Administration And dosage
Shake well. Using aseptic technique, inject 1 mL intramuscularly preferably in the hind quarters. For primary vaccination give 3 doses at intervals of 3 weeks. Foals vaccinated when less than 3 months of age should receive an additional dose at 6 months. Revaccinate annually and prior to anticipated exposure, using a single 1 mL dose. Use a separate needle for each injection.
Strepvax II Caution
Store at 35°-45°F (2°-7°C). Protect from freezing. Use entire contents when first opened.
Field reports suggest that certain hypersensitive individuals may demonstrate local or generalized reactions, sometimes severe, following exposure to streptococcal proteins. Field studies indicate that postvaccinal exercise will appreciably decrease the incidence and duration of reactions. Do not vaccinate within 21 days before slaughter.
Anaphylactoid reactions may occur following use.
Antidote
Epinephrine.
Description
Strepvax® II is a concentrated, aluminum hydroxide - absorbed suspension of purified antigens derived from S. equi cells. Strepvax II contains the antigenic protein of S. equi but is essentially free of the toxic and irritant substances present in whole cell bacterins.
Actions And Uses
Strepvax II has been observed to decrease the incidence and severity of strangles in controlled efficacy studies as well as under field conditions. When its use is combined with good hygiene and the segregation of affected individuals, Strepvax II will help to limit the occurrence of clinical disease and to minimize sequelae.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Mo 64506 U.s.a.
U.s. Veterinary License No. 124
Code
1 Dose/1 mL
131-715
31701-03
10 - 1 dose/1 mL Syringes
131-715
31702-03
10 Doses/10 mL
431-725
31703-02, 31704-03
Nac No.
10281021
BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone: 800-325-9167
Fax: 816-236-2717
Website: www.bevaccinesmart.com
www.bi-vetmedica.com
www.productionvalues.us
www.prrsresearch.com
www.thinkmetacam.com
www.vetera-vaccines.com
www.vetmedin-us.com
www.yourdogsheart.com
Email: info@productionvalues.us
Every effort has been made to ensure the accuracy of the Strepvax II information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.
